lensgeninc

An ophthalmic medical device company that has developed a biomimetic, Curvature Changing Fluid-Optic IOLdesigned for the treatment of cataracts and presbyopia.

[lensgeninc @lensgeninc]

https://t.co/ufYsprn8VE

[lensgeninc @lensgeninc]

https://t.co/g5iVfgeQV7

[lensgeninc @lensgeninc]

LensGen’s participation in TiE Young Entrepreneurs (TYE) OC 2023 Summer Shadow Day Program was a huge success!

@TiEGlobal

[lensgeninc @lensgeninc]

Sumit Garg, M.D. Presented Thirty-Six Months Grail Study Visual Outcomes at the American Society of Cataract and Refractive Surgery Conference

https://t.co/mzUeNwdOsC

[lensgeninc @lensgeninc]

#btigophthalmologyday #ophthalmology #healthcare #medicaltechnology #btig #btigconferenceandevents #btigcorporateaccess #btigresearch #btiginvestmentbanking

[lensgeninc @lensgeninc]

Ramgopal Rao, CEO, LensGen, Inc. is presenting at BTIG’s Ophthalmology Day 2022, on Tuesday, November 29, 2022.

[lensgeninc @lensgeninc]

https://t.co/GRBtabm1iQ

[lensgeninc @lensgeninc]

https://t.co/l7IVOzNXBA

[lensgeninc @lensgeninc]

LensGen is excited to support and attend @OctaneOC's Ophthalmology Tech Summit on June 16 and 17 at the Balboa Bay Resort in Newport Beach! To register and learn more: https://t.co/HpJEpVpTGD

[lensgeninc @lensgeninc]

#LSIUSA22

[lensgeninc @lensgeninc]

LensGen® Receives IDE Approval from the U.S. FDA to Begin Clinical Study of the Juvene® Presbyopia-Correcting Intr... https://t.co/DA3hEiUdQv